The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

Eli Lilly & Co.’s blockbuster obesity shot Zepbound helped people with type 1 diabetes lose more than a fifth of their body ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

The weight management drug Zepbound will now be sold in lower-cost vials in addition to preloaded injector pens, according to ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

“Extremes in blood sugar can impact mood,” said Tara Schmidt, lead dietitian at the Mayo Clinic Diet, an online weight loss program. “For example, someone who is experiencing hypoglycemia, or low ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the ...